MT-CO1 and mastocytosis: In this study, based on a large retrospective series of mastocytosis patients we confirmed that a significant fraction (13%) of adults diagnosed with mastocytosis who had previously used these drugs did actually experienced DHRs after using them, less than half of them being reactors to multiple NSAIDs or other COXi.